ADHD patients in supervised medication trials suffer severe, rapid psychological side effects (like deep depressive crashes) and have no immediate way to log symptoms or get an urgent response from their uncommunicative prescribing clinics.
ADHD patients undergoing supervised medication trials experience severe, destabilizing side effects from trial rotations and struggle to get immediate clinical support or remain on a previously successful medication.
I tried to reach my clinic. I couldn’t get through by phone, so I emailed, and they didn’t answer.
postAbbys is Strong
Abbys is Strong
Patients actively testing newly prescribed stimulants who experience destabilizing emotional or physical side effects and lack real-time clinic support.
Repeated pattern of patients forced onto alternative stimulant rotations (e.g., Methylphenidate) despite previous drug success, followed by clinic unresponsiveness during severe emotional crashes.
Unlike generic mood trackers, this is an actionable medical bridge built explicitly for the unique timeline of psychiatric medication trials, focusing entirely on getting the patient safely off a bad drug rotation by forcing provider attention.
A patient-facing symptom log and automated clinical escalating bridge that detects severe mood dips during ADHD medication rotation, generates a standardized clinical urgency report, and bypasses typical gatekeepers via structured clinic messaging.
Users express extreme despair over 'crumbling' lives and feeling completely broken by bad drug trials; they are highly motivated to spend $19 to escape a week-long administrative black hole when a medication makes them deeply depressed.
“Log severe ADHD medication side effects and flag your clinic instantly.”
A patient-facing symptom log and automated clinical escalating bridge that detects severe mood dips during ADHD medication rotation, generates a standardized clinical urgency report, and bypasses typical gatekeepers via structured clinic messaging.
Partner with private ADHD specialized telehealth clinics, and engage directly in communities like r/ADHD and r/Adderall where users explicitly post while experiencing medication crashes.
If a user reports severe depressive or suicidal side effects, the app must safely offload liability to immediate crisis hotlines rather than relying solely on clinic routing.
Bypassing clinic gatekeepers requires robust, reliable automated communication channels (Fax, EHR API, or structured email) that doctors will actually read.
Once a patient successfully identifies their ideal ADHD medication dose, their need for acute trial tracking drops to zero.
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoThis opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 8/10 against 3 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
It sits at the intersection of "adhd", "healthcare", "mental-health", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.
